The use of high doses of insulin together with glycemic support, also known as hyperinsulinemia–euglycemia therapy (HIET), was initially used in toxicology in poisoning beta-blockers and calcium antagonists [17,18,45]. The gene discussed is INS; the disease is Hyperinsulinemia.